{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:41:25Z","timestamp":1780926085916,"version":"3.54.1"},"reference-count":16,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Protocols"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sj\u00f6gren's disease (SjD), or Sj\u00f6gren's syndrome, is a chronic autoimmune condition that targets exocrine glands, leading to dryness symptoms. With the treatment plan for SjD having remained unchanged for the past decade, there is a critical need for innovative therapeutic strategies. To bridge the gap between mouse models and human patients, we have established a mouse model of experimental Sjo\u0308gren's syndrome with a human immune system (HIS\u2010ESS). Immunizing mice with antigens derived from human salivary epithelial cells results in HIS\u2010ESS mice that display clinical features of SjD that include salivary dysfunction, increased serum autoantibodies, and dysregulated immune responses. Effector T cell subsets such as Th1, Th17, and T follicular helper (Tfh) cells are also elevated in HIS\u2010ESS mice. Thus, this humanized model can effectively recapitulate SjD outcomes and immunopathogenesis, offering a promising platform for drug screening and preclinical research. \u00a9 2025 Wiley Periodicals LLC.<\/jats:p><jats:p><jats:bold>Basic Protocol<\/jats:bold>: Establishment of humanized mouse models of primary Sj\u00f6gren's syndrome<\/jats:p><jats:p><jats:bold>Support Protocol 1<\/jats:bold>: Irradiation of neonatal mice<\/jats:p><jats:p><jats:bold>Support Protocol 2<\/jats:bold>: Preparation of proteins from A\u2010253 human salivary epithelial cells<\/jats:p><jats:p><jats:bold>Support Protocol 3<\/jats:bold>: Determination of mouse saliva flow rate<\/jats:p>","DOI":"10.1002\/cpz1.70178","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T11:39:16Z","timestamp":1752493156000},"source":"Crossref","is-referenced-by-count":1,"title":["Humanized Mouse Models of Sj\u00f6gren's Disease"],"prefix":"10.1002","volume":"5","author":[{"given":"Sulan","family":"Yu","sequence":"first","affiliation":[{"name":"School of Chinese Medicine the University of Hong Kong  Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9065-2744","authenticated-orcid":false,"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine the University of Hong Kong  Hong Kong SAR China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology The University of Hong Kong  Hong Kong SAR China"},{"name":"Department of Chinese Medicine The University of Hong Kong\u2010Shenzhen Hospital  Shen Zhen China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42683"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170901"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102013\u2010204584"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxr066"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.2731"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063166"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.110"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101217"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00203"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102016\u2010210571"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1422.044"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.317"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.10.004"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107524"},{"issue":"1","key":"e_1_2_8_16_1","first-page":"2074","article-title":"Targeting T follicular helper cells in Sj\u00f6gren's disease by calycosin","volume":"84","author":"Yu S. L.","year":"2025","journal-title":"EULAR Abstract"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.03.001"}],"container-title":["Current Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpz1.70178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T13:39:09Z","timestamp":1754573949000},"score":1,"resource":{"primary":{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/10.1002\/cpz1.70178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1002\/cpz1.70178"],"URL":"https:\/\/doi.org\/10.1002\/cpz1.70178","archive":["Portico"],"relation":{},"ISSN":["2691-1299","2691-1299"],"issn-type":[{"value":"2691-1299","type":"print"},{"value":"2691-1299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"article-number":"e70178"}}